Ignite Creation Date:
2024-05-06 @ 10:09 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03175224
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2017-06-01
Brief Title:
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Sponsor:
Apollomics Inc
Organization:
Apollomics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Exon 14 Skipping |
| Solid Tumors |
| Advanced Cancer |
| Renal Cancer |
| Gastric Cancer |
| Gastroesophageal Junction Adenocarcinoma |
| NSCLC |
| Lung Cancer |
| Brain Tumor |
| Glioblastoma Multiforme |
| EGFR Gene Mutation |
| MET Amplification |
| HGF |
| Thyroid Cancer |
| Pancreatic Cancer |
| Colon Cancer |
| MET Alteration |
| MET Fusion |